Results 1 to 10 of about 831,586 (304)

Platelet Transfusion

Current Opinion in Hematology
Purpose of review Platelet transfusions, used as prophylaxis or treatment for bleeding, are potentially life-saving. In many countries, demand for platelet transfusion is rising. Platelets are a limited and costly resource, and it is vital that they are used appropriately.
Agarwal A, Khan AI, Anwer F.
europepmc   +4 more sources

Platelet Transfusion in Patients With Sepsis and Thrombocytopenia: A Propensity Score-Matched Analysis Using a Large ICU Database

Frontiers in Medicine, 2022
PurposeSepsis with thrombocytopenia is highly prevalent in critically ill intensive care unit (ICU) patients and is associated with adverse outcomes. Platelet transfusion is the primary treatment of choice. However, evidence for the beneficial effects of
Shuangjun He, Chenyu Fan, Jun Ma, Chao Tang, Yi Chen   +4 more
doaj   +2 more sources

Platelet Transfusion: And Update on Challenges and Outcomes

Journal of Blood Medicine, 2020
Pilar Solves Alcaina Blood Bank, Hematology Service, Hospital Universitari I Politècnic La Fe, Valencia, CIBERONC, Instituto Carlos III, Madrid, SpainCorrespondence: Pilar Solves AlcainaBlood Bank, Hematology Service, Hospital Universitari I Polit&
Solves Alcaina P
doaj   +2 more sources

Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial

Lancet, The, 2016
BACKGROUND Platelet transfusion after acute spontaneous primary intracerebral haemorrhage in people taking antiplatelet therapy might reduce death or dependence by reducing the extent of the haemorrhage.
Ludo Beenen, Yvo Roos, Henk Marquering   +2 more
exaly   +2 more sources

Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion

Transfusion Medicine Reviews, 2020
Refractoriness to platelet transfusion is a common clinical problem encountered by the transfusion medicine specialist. It is well recognized that most causes of refractoriness to platelet transfusion are not a consequence of alloimmunization to human ...
Roger Belizaire
exaly   +2 more sources

Platelet Transfusion for Patients with Cancer: An Update [PDF]

Transfusion Medicine and Hemotherapy
Background: Platelet transfusion is essential for preventing and treating hemorrhage in oncology patients and can markedly improve quality of life and survival.
Yan Wang, Lvling Zhang, Na Ma, Yufeng Wang   +3 more
doaj   +2 more sources

ABO-identical versus incompatible platelet transfusion in patients with intracranial hemorrhage. [PDF]

PLoS ONE
BackgroundPatients with spontaneous and traumatic intracranial hemorrhage (ICH) are frequently transfused platelets to treat thrombocytopenia, platelet function defects, and reverse antiplatelet drugs.
Lauren K Dunn, Emily Venner, Matthew Nguyen, Jose Perdomo Trejo, Zachary Holley, Bhiken I Naik, Jenna Khan, Michael Mazzeffi   +7 more
doaj   +2 more sources

The role of platelet transfusion in modulating platelet indices and leukocyte dynamics in dengue fever patients [PDF]

Asian Journal of Transfusion Science
Dengue fever, a viral illness transmitted by Aedes mosquitoes, is marked by a reduction in platelet count (PLT) and changes in blood parameters, which increase the risk of complications such as hemorrhage.
Mohd Afzal, M. Chandrasekar, Ashok Kumar Sah, Shagun Agarwal   +3 more
doaj   +2 more sources

Optimizing platelet transfusion practices in hemato-oncology patients: A comprehensive analysis at a tertiary care oncology center [PDF]

Asian Journal of Transfusion Science
BACKGROUND AND AIMS: Platelet transfusions play a crucial role in managing thrombocytopenia in hemato-oncology patients. This study aimed to analyze platelet transfusion practices and evaluate the correlation between clinical and laboratory parameters ...
Shashank Ojha, P. Nagaraju, Najnin Ladkhan Bangi, Abhaykumar Milind Gupta   +3 more
doaj   +2 more sources

Platelet transfusion refractoriness [PDF]

British Journal of Haematology, 2008
SummaryThe platelet, a fascinating anucleate cell, is critically important for haemostasis. Platelet transfusions have greatly reduced the incidence of major haemorrhagic complications associated with the management of haematological and oncological disorders. However, some patients fail to receive the full benefit of platelet transfusions because they
Eldad Hod
exaly   +3 more sources